Skip to main content
Top
Published in: Journal of Translational Medicine 1/2012

Open Access 01-12-2012 | Research

Effects of helium and air inhalation on the innate and early adaptive immune system in healthy volunteers ex vivo

Authors: Gezina TML Oei, Kirsten F Smit, Djai vd Vondervoort, Daniel Brevoord, Arjan Hoogendijk, Catharina W Wieland, Markus W Hollmann, Benedikt Preckel, Nina C Weber

Published in: Journal of Translational Medicine | Issue 1/2012

Login to get access

Abstract

Background

Helium inhalation protects myocardium, brain and endothelium against ischemia/reperfusion injury in animals and humans, when applied according to specific “conditioning” protocols. Before widespread use of this “conditioning” agent in clinical practice, negative side effects have to be ruled out. We investigated the effect of prolonged helium inhalation on the responsiveness of the human immune response in whole blood ex vivo.

Methods

Male healthy volunteers inhaled 30 minutes heliox (79%He/21%O2) or air in a cross over design, with two weeks between measurements. Blood was withdrawn at T0 (baseline), T1 (25 min inhalation) and T2-T5 (1, 2, 6, 24 h after inhalation) and incubated with lipopolysaccharide (LPS), lipoteichoic acid (LTA), T-cell stimuli anti-CD3/ anti-CD28 (TCS) or RPMI (as control) for 2, 4 and 24 hours or not incubated (0 h). An additional group of six volunteers inhaled 60 minutes of heliox or air, followed by blood incubation with LPS and RPMI. Tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), interleukin-6 (IL-6), interleukin-8 (IL-8), interferon-γ (IFN-γ) and interleukin-2 (IL-2) was analyzed by cytometric bead array. Statistical analysis was performed by the Wilcoxon test for matched samples.

Results

Incubation with LPS, LTA or TCS significantly increased TNF-α, IL-1β, IL-6, IL-8, IFN-γ and IL-2 in comparison to incubation with RPMI alone. Thirty min of helium inhalation did not influence the amounts of TNF-α, IL-1β, IL-6, IL-8, IFN-γ and IL-2 in comparison to air. Sixty min of helium inhalation did not affect cytokine production after LPS stimulation.

Conclusions

We conclude that 79% helium inhalation does not affect the responsiveness of the human immune system in healthy volunteers.

Trial registration

Dutch Trial Register:http://​www.​trialregister.​nl/​ NTR2152
Appendix
Available only for authorised users
Literature
1.
go back to reference Oei GT, Weber NC, Hollmann MW, Preckel B: Cellular effects of helium in different organs. Anesthesiology. 2010, 112: 1503-1510. 10.1097/ALN.0b013e3181d9cb5e.CrossRefPubMed Oei GT, Weber NC, Hollmann MW, Preckel B: Cellular effects of helium in different organs. Anesthesiology. 2010, 112: 1503-1510. 10.1097/ALN.0b013e3181d9cb5e.CrossRefPubMed
2.
go back to reference Weber NC, Preckel B, Schlack W: The effect of anaesthetics on the myocardium: New insights into myocardial protection. Eur J Anaesthesiol. 2005, 22: 647-657. 10.1017/S0265021505001080.CrossRefPubMed Weber NC, Preckel B, Schlack W: The effect of anaesthetics on the myocardium: New insights into myocardial protection. Eur J Anaesthesiol. 2005, 22: 647-657. 10.1017/S0265021505001080.CrossRefPubMed
3.
go back to reference Pagel PS, Krolikowski JG, Shim YH, Venkatapuram S, Kersten JR, Weihrauch D, Waltier DC, Pratt PFJ: Noble gases without anesthetic properties protect myocardium against infarction by activating prosurvival signaling kinases and inhibiting mitochondrial permeability transition in vivo. Anesth Analg. 2007, 105: 562-569. 10.1213/01.ane.0000278083.31991.36.CrossRefPubMed Pagel PS, Krolikowski JG, Shim YH, Venkatapuram S, Kersten JR, Weihrauch D, Waltier DC, Pratt PFJ: Noble gases without anesthetic properties protect myocardium against infarction by activating prosurvival signaling kinases and inhibiting mitochondrial permeability transition in vivo. Anesth Analg. 2007, 105: 562-569. 10.1213/01.ane.0000278083.31991.36.CrossRefPubMed
4.
go back to reference Heinen A, Huhn R, Smeele KM, Zuurbier CJ, Schlack W, Preckel B, Weber NC: Helium-induced preconditioning in young and old rat heart: Impact of mitochondrial Ca(2+) -sensitive potassium channel activation. Anesthesiology. 2010, 109: 830-836.CrossRef Heinen A, Huhn R, Smeele KM, Zuurbier CJ, Schlack W, Preckel B, Weber NC: Helium-induced preconditioning in young and old rat heart: Impact of mitochondrial Ca(2+) -sensitive potassium channel activation. Anesthesiology. 2010, 109: 830-836.CrossRef
5.
go back to reference Pan Y, Zhang H, VanDeripe DR, Cruz-Flores S, Panneton WM: Heliox and oxygen reduce infarct volume in a rat model of focal ischemia. Exp Neurol. 2007, 205: 587-590. 10.1016/j.expneurol.2007.03.023.CrossRefPubMed Pan Y, Zhang H, VanDeripe DR, Cruz-Flores S, Panneton WM: Heliox and oxygen reduce infarct volume in a rat model of focal ischemia. Exp Neurol. 2007, 205: 587-590. 10.1016/j.expneurol.2007.03.023.CrossRefPubMed
6.
go back to reference Jawad N, Rizvi M, Gu J, Adeyi O, Tao G, Maze M, Ma D: Neuroprotection (and lack of neuroprotection) afforded by a series of noble gases in an in vitro model of neuronal injury. Neurosci Lett. 2009, 460: 232-236. 10.1016/j.neulet.2009.05.069.CrossRefPubMed Jawad N, Rizvi M, Gu J, Adeyi O, Tao G, Maze M, Ma D: Neuroprotection (and lack of neuroprotection) afforded by a series of noble gases in an in vitro model of neuronal injury. Neurosci Lett. 2009, 460: 232-236. 10.1016/j.neulet.2009.05.069.CrossRefPubMed
7.
go back to reference Huhn R, Heinen A, Weber NC, Kerindongo RP, Oei GT, Hollmann MW, Schlack W, Preckel B: Helium induced early preconditioning and postconditioning are abolished in obese Zucker rats in vivo. J Pharmacol Exp Ther. 2009, 329: 600-607. 10.1124/jpet.108.149971.CrossRefPubMed Huhn R, Heinen A, Weber NC, Kerindongo RP, Oei GT, Hollmann MW, Schlack W, Preckel B: Helium induced early preconditioning and postconditioning are abolished in obese Zucker rats in vivo. J Pharmacol Exp Ther. 2009, 329: 600-607. 10.1124/jpet.108.149971.CrossRefPubMed
8.
go back to reference Huhn R, Heinen A, Weber NC, Hieber S, Hollmann MW, Schlack W, Preckel B: Helium-induced late preconditioning in the rat heart in vivo. Br J Anaesth. 2009, 102: 614-619. 10.1093/bja/aep042.CrossRefPubMed Huhn R, Heinen A, Weber NC, Hieber S, Hollmann MW, Schlack W, Preckel B: Helium-induced late preconditioning in the rat heart in vivo. Br J Anaesth. 2009, 102: 614-619. 10.1093/bja/aep042.CrossRefPubMed
9.
go back to reference Smit KF, Weber NC, Stroes ES, Oei GT, Hollmann MW, Preckel B: Helium induces early and late preconditioning in human endothelium in vivo [abstract]. Anesth Analg. 2010, 110 (suppl): S-99- Smit KF, Weber NC, Stroes ES, Oei GT, Hollmann MW, Preckel B: Helium induces early and late preconditioning in human endothelium in vivo [abstract]. Anesth Analg. 2010, 110 (suppl): S-99-
10.
go back to reference Li Y, Yhang XZ, Zhu B, Xue Z: Desflurane preconditioning inhibits endothelial nuclear factor-κ-B activation by targeting the proximal end of tumor necrosis factor-α signaling. Anesth Analg. 2008, 106: 1473-1479. 10.1213/ane.0b013e318168b3f2.CrossRefPubMed Li Y, Yhang XZ, Zhu B, Xue Z: Desflurane preconditioning inhibits endothelial nuclear factor-κ-B activation by targeting the proximal end of tumor necrosis factor-α signaling. Anesth Analg. 2008, 106: 1473-1479. 10.1213/ane.0b013e318168b3f2.CrossRefPubMed
11.
go back to reference Hamra JG, Yaksh TL: Halothane inhibits T cell proliferation and interleukin-2 receptor expression in rats. Immunopharmacol Immunotoxicol. 1996, 18: 323-336. 10.3109/08923979609052739.CrossRefPubMed Hamra JG, Yaksh TL: Halothane inhibits T cell proliferation and interleukin-2 receptor expression in rats. Immunopharmacol Immunotoxicol. 1996, 18: 323-336. 10.3109/08923979609052739.CrossRefPubMed
12.
go back to reference Matsuoka H, Kurosawa S, Horinouchi T, Kato M, Hashimoto Y: Inhalation anesthetics induce apoptosis in normal peripheral lymphocytes in vitro. Anesthesiology. 2001, 95: 1467-1472. 10.1097/00000542-200112000-00028.CrossRefPubMed Matsuoka H, Kurosawa S, Horinouchi T, Kato M, Hashimoto Y: Inhalation anesthetics induce apoptosis in normal peripheral lymphocytes in vitro. Anesthesiology. 2001, 95: 1467-1472. 10.1097/00000542-200112000-00028.CrossRefPubMed
13.
go back to reference Puig NR, Ferrero P, Bay ML, Hidalgo G, Valenti J, Amerio N, Elena G: Effects of sevoflurane general anesthesia: Immunological studies in mice. Int Immunopharmacol. 2002, 2: 95-104. 10.1016/S1567-5769(01)00151-5.CrossRefPubMed Puig NR, Ferrero P, Bay ML, Hidalgo G, Valenti J, Amerio N, Elena G: Effects of sevoflurane general anesthesia: Immunological studies in mice. Int Immunopharmacol. 2002, 2: 95-104. 10.1016/S1567-5769(01)00151-5.CrossRefPubMed
14.
go back to reference van der Poll T, Jansen J, Endert E, Sauerwein HP, van Deventer SJ: Noradrenaline inhibits lipopolysaccharide-induced tumor necrosis factor and interleukin 6 production in human whole blood. Infect Immun. 1994, 62: 2046-2050.PubMedPubMedCentral van der Poll T, Jansen J, Endert E, Sauerwein HP, van Deventer SJ: Noradrenaline inhibits lipopolysaccharide-induced tumor necrosis factor and interleukin 6 production in human whole blood. Infect Immun. 1994, 62: 2046-2050.PubMedPubMedCentral
15.
go back to reference Draing C, Sigel S, Deiniger S, Traub S, Munke R, Mayer C, Hareng L, Hartung T, von Aulock S, Hermann C: Cytokine induction by Gram-positive bacteria. Immunobiology. 2008, 213: 285-296.PubMed Draing C, Sigel S, Deiniger S, Traub S, Munke R, Mayer C, Hareng L, Hartung T, von Aulock S, Hermann C: Cytokine induction by Gram-positive bacteria. Immunobiology. 2008, 213: 285-296.PubMed
16.
go back to reference Ginsburg I: Role of lipoteichoic acid in infection and inflammation. Lancet Infect Dis. 2002, 2: 171-179. 10.1016/S1473-3099(02)00226-8.CrossRefPubMed Ginsburg I: Role of lipoteichoic acid in infection and inflammation. Lancet Infect Dis. 2002, 2: 171-179. 10.1016/S1473-3099(02)00226-8.CrossRefPubMed
17.
go back to reference von Aulock S, Morath S, Hareng L, Knapp S, van Kessel KPM, van Strijp JAG, Hartung T: Lipoteichoic acid from Staphylocuccus aureus is a potent stimulus for neutrophil recruitment. Immunobiology. 2003, 208: 413-422. 10.1078/0171-2985-00285.CrossRefPubMed von Aulock S, Morath S, Hareng L, Knapp S, van Kessel KPM, van Strijp JAG, Hartung T: Lipoteichoic acid from Staphylocuccus aureus is a potent stimulus for neutrophil recruitment. Immunobiology. 2003, 208: 413-422. 10.1078/0171-2985-00285.CrossRefPubMed
18.
go back to reference van Lier RAW, Brouwer M, Rebel VI, van Noessel CJM, Aarden LA: Immobilized anti-CD3 monoclonal antibodies induce accessory cell dependent lymphokine production, proliferation and helper activity in human T lymphocytes. Immunology. 1989, 68: 45-50.PubMedPubMedCentral van Lier RAW, Brouwer M, Rebel VI, van Noessel CJM, Aarden LA: Immobilized anti-CD3 monoclonal antibodies induce accessory cell dependent lymphokine production, proliferation and helper activity in human T lymphocytes. Immunology. 1989, 68: 45-50.PubMedPubMedCentral
19.
go back to reference Trickett A, Lam Kwan Y: T cell stimulation and expansion using anti-CD3/CD28 beads. J Immunol Methods. 2003, 275: 251-255. 10.1016/S0022-1759(03)00010-3.CrossRefPubMed Trickett A, Lam Kwan Y: T cell stimulation and expansion using anti-CD3/CD28 beads. J Immunol Methods. 2003, 275: 251-255. 10.1016/S0022-1759(03)00010-3.CrossRefPubMed
20.
go back to reference Lucchinetti E, Wacker J, Maurer C, Keel M, Haerter L, Zaugg K, Zaugg M: Helium breathing provides modest antiinflammatory, but no endothelial protection against ischemia-reperfusion injury in humans in vivo. Anesth Analg. 2009, 109: 101-108. 10.1213/ane.0b013e3181a27e4b.CrossRefPubMed Lucchinetti E, Wacker J, Maurer C, Keel M, Haerter L, Zaugg K, Zaugg M: Helium breathing provides modest antiinflammatory, but no endothelial protection against ischemia-reperfusion injury in humans in vivo. Anesth Analg. 2009, 109: 101-108. 10.1213/ane.0b013e3181a27e4b.CrossRefPubMed
21.
go back to reference Nawab US, Touch SMT, Irwin-Sherman T, Blackson TJ, Greenspan JS, Zhu G, Shaffer TH, Wolfson MR: Heliox attenuates lung inflammation and structural alterations in acute lung injury. Pediatr Pulmonol. 2005, 40: 524-532. 10.1002/ppul.20304.CrossRefPubMed Nawab US, Touch SMT, Irwin-Sherman T, Blackson TJ, Greenspan JS, Zhu G, Shaffer TH, Wolfson MR: Heliox attenuates lung inflammation and structural alterations in acute lung injury. Pediatr Pulmonol. 2005, 40: 524-532. 10.1002/ppul.20304.CrossRefPubMed
22.
go back to reference Garcia C, Julier K, Bestmann L, Zollinger A, von Segesser LK, Pasch T, Spahn DR, Zaugg M: Preconditioning with sevoflurane decreases PECAM-1 expression and improves one-year cardiovascular outcome in coronary artery bypass graft surgery. Br J Anaest. 2005, 94: 159-165. 10.1093/bja/aei026.CrossRef Garcia C, Julier K, Bestmann L, Zollinger A, von Segesser LK, Pasch T, Spahn DR, Zaugg M: Preconditioning with sevoflurane decreases PECAM-1 expression and improves one-year cardiovascular outcome in coronary artery bypass graft surgery. Br J Anaest. 2005, 94: 159-165. 10.1093/bja/aei026.CrossRef
23.
go back to reference Amr YM, Yassin IM: Cardiac protection during on-pump coronary artery bypass grafting: ischemic versus isoflurane preconditioning. Semin Cardiothorac Vasc Anesth. 2010, 14: 205-211. 10.1177/1089253210376839.CrossRefPubMed Amr YM, Yassin IM: Cardiac protection during on-pump coronary artery bypass grafting: ischemic versus isoflurane preconditioning. Semin Cardiothorac Vasc Anesth. 2010, 14: 205-211. 10.1177/1089253210376839.CrossRefPubMed
24.
go back to reference Frässdorf J, Borowski A, Ebel D, Feindt P, Hermes M, Meemann T, Weber R, Müllenheim J, Weber NC, Preckel B, Schlack W: Impact of preconditioning protocol on anesthetic-induced cardioprotection in patients having coronary artery bypass surgery. J Thorac Cardiovasc Surg. 2009, 137: 1436-1442. 10.1016/j.jtcvs.2008.04.034.CrossRefPubMed Frässdorf J, Borowski A, Ebel D, Feindt P, Hermes M, Meemann T, Weber R, Müllenheim J, Weber NC, Preckel B, Schlack W: Impact of preconditioning protocol on anesthetic-induced cardioprotection in patients having coronary artery bypass surgery. J Thorac Cardiovasc Surg. 2009, 137: 1436-1442. 10.1016/j.jtcvs.2008.04.034.CrossRefPubMed
25.
go back to reference Hurford WE, Cheifetz IM: Should heliox be used for mechanically ventilated patients?. Respir Care. 2007, 52: 582-591.PubMed Hurford WE, Cheifetz IM: Should heliox be used for mechanically ventilated patients?. Respir Care. 2007, 52: 582-591.PubMed
26.
27.
go back to reference Goris MGA, Wagenaar JFP, Hartskeerl RA, Van Gorp EC, Schuller S, Monahan AM, Van Der Poll T, Van't Veer C: Potent innate immune response to pathogenic Leptospira in human whole blood. PLoS One. 2011, 6: e18279-10.1371/journal.pone.0018279.CrossRefPubMedPubMedCentral Goris MGA, Wagenaar JFP, Hartskeerl RA, Van Gorp EC, Schuller S, Monahan AM, Van Der Poll T, Van't Veer C: Potent innate immune response to pathogenic Leptospira in human whole blood. PLoS One. 2011, 6: e18279-10.1371/journal.pone.0018279.CrossRefPubMedPubMedCentral
28.
go back to reference Schultz MJ, Speelman P, Hack EC, Buurman WA, van Deventer SJ, van der Poll T: Intravenous infusion of erythromycin inhibits CXC chemokine production, but augments neutrophil degranulation in whole blood stimulated with Streptococcus pneumonia. J Antimicrob Chemother. 2000, 46: 235-240. 10.1093/jac/46.2.235.CrossRefPubMed Schultz MJ, Speelman P, Hack EC, Buurman WA, van Deventer SJ, van der Poll T: Intravenous infusion of erythromycin inhibits CXC chemokine production, but augments neutrophil degranulation in whole blood stimulated with Streptococcus pneumonia. J Antimicrob Chemother. 2000, 46: 235-240. 10.1093/jac/46.2.235.CrossRefPubMed
29.
go back to reference van Westerloo DJ, Choi G, Lowenberg EC, Truijen J, de Vos AF, Endert E, Meijers JC, Zhou L, Pereira MP, Queiroz KC, Diks SH, Levi M, Peppelenbosch MP, van der Poll T: Acute stress elicited by bungee jumping suppresses human innate immunity. I Mol Med. 2011, 17: 180-188.PubMed van Westerloo DJ, Choi G, Lowenberg EC, Truijen J, de Vos AF, Endert E, Meijers JC, Zhou L, Pereira MP, Queiroz KC, Diks SH, Levi M, Peppelenbosch MP, van der Poll T: Acute stress elicited by bungee jumping suppresses human innate immunity. I Mol Med. 2011, 17: 180-188.PubMed
30.
go back to reference Aulock S, Deiniger S, Draing C, Gueinzius K, Dehus O, Hermann C: Gender difference in cytokine secretion on immune stimulation with LPS and LTA. J Interferon Cytokine Res. 2006, 26: 887-892. 10.1089/jir.2006.26.887.CrossRefPubMed Aulock S, Deiniger S, Draing C, Gueinzius K, Dehus O, Hermann C: Gender difference in cytokine secretion on immune stimulation with LPS and LTA. J Interferon Cytokine Res. 2006, 26: 887-892. 10.1089/jir.2006.26.887.CrossRefPubMed
Metadata
Title
Effects of helium and air inhalation on the innate and early adaptive immune system in healthy volunteers ex vivo
Authors
Gezina TML Oei
Kirsten F Smit
Djai vd Vondervoort
Daniel Brevoord
Arjan Hoogendijk
Catharina W Wieland
Markus W Hollmann
Benedikt Preckel
Nina C Weber
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Journal of Translational Medicine / Issue 1/2012
Electronic ISSN: 1479-5876
DOI
https://doi.org/10.1186/1479-5876-10-201

Other articles of this Issue 1/2012

Journal of Translational Medicine 1/2012 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.